Guggenheim Active Allocation Fund Common Shares of Beneficial Interest (GUG)
FairStock Score: 38/100 — MIXED
Key Financials
| Current Price | $13.75 |
| Market Cap | $515M |
| P/E Ratio | 8.33 |
| ROE | —% |
| Dividend Yield | 10.36% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach GUG as a fund, not an operating business. At the 2026-10-13 close of $13.94, FairStock's P/E calculation is 8.45, and its Graham Number comes to $24.88, implying a 43.97% margin of safety. A 10.22% dividend yield is eye-catching, and the shares sit near the bottom of their 52-week range of $13.65-$16.46. On those price-based measures alone, this looks cheap. But Graham demanded quality and stability, not just a low price. The financial-health signals are poor: a Piotroski F-Score of 2/9 and an Altman Z-Score of 0.81. The latter is well below the 1.8 threshold often used to flag distress, and the FairStock Score is only 38/100. I have no P/B, ROE, ROCE, debt-to-equity, revenue growth, profit growth, or beta to test the business, and the Lynch category is none because there are only 0 years of filed results when 3 are needed. That means no multi-year track record. The high yield may compensate patient owners if it is covered and the portfolio holds value, but the data do not let me confirm that. A true moat is not visible here; the fund's results depend on management and markets. My conclusion: statistically cheap, but unproven and financially fragile on the supplied metrics. I would want more filed history, stable distributions, and much stronger balance-sheet scores before trusting the margin of safety.
In plain English: Guggenheim Active Allocation Fund is an investment fund that holds assets and pays out income to shareholders. Based on the numbers provided, it looks cheap compared with its earnings and a value estimate, and it pays a very high dividend. But its financial health scores are weak and there is little history to judge, so the low price may carry real risk.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer